|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Angina or cardiac disease, previously undiagnosed |
|
diastolic blood pressure reduction, maternal |
|
hyperglycemia, maternal |
|
pulmonary edema |
|
tachycardia or other cardiac arrhythmias, maternal and fetal |
|
Agranulocytosis or leukopenia |
|
hepatic function impairment or hepatitis |
|
Erythema |
|
headache |
|
nausea |
|
palpitations |
|
trembling |
|
vomiting |
|
Psychological symptoms |
|
skin rash |
|
Shortness of breath |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Abruptio placentae |
|
>> Hemorrhage, maternal |
|
>> Placenta previa |
|
>> Preeclampsia, mild to moderate |
|
Allergy or sensitivity to ritodrine or sulfites |
|
>> Diabetes mellitus |
|
Hypertension |
|
Migraine headaches |
|
|
ADULT DOSE:
|
|
Tocolytic-
Initial: Oral, 10 mg thirty minutes before the intravenous infusion is discontinued, then 10 mg every two hours for twenty-four hours.
Maintenance: Oral, 10 to 20 mg every four to six hours until term (or until the 37th week of gestation) or as medical judgment dictates. |
|
MAXIMUM ADULT DOSE:
|
|
Up to 120 mg a day.
|
|
PEDIATRIC DOSE:
|
|
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|